Home > Boards > iHub Talk > Other > Vendit's Area 51

TEST

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Jeff Jordan NV Member Profile
Member Level 
Followed By 5
Posts 108
Boards Moderated 1
Alias Born 03/19/01
160x600 placeholder
Avenue Therapeutics Shares Rise as FDA Panel to Meet on Appeal
By Colin Kellaher
Kimberly-Clark on Track for Lowest Close Since April 2020 -- Data Talk
Linde Names Sanjiv Lamba as New Chief Executive
Texas Factory Production Eased in October -- Dallas Fed
UBS to Sell Spanish Wealth-Management Business to Singular Bank
Top Company News of the Day
Tesla Up Nearly 7%, on Track for Record High Close -- Data Talk
Creatd Shares Rise 42% on Sale of Donald Trump Photos
Kimberly-Clark Expects FX to Boost Full-Year Sales -- Currency Comment
Bakkt Shares Rise 25% After Partnership With Mastercard
Belgium Business Confidence Stabilizes in October
Aurinia Pharmaceuticals Shares Rally on Report of Bristol Myers Interest
Moderna Says Interim Data Positive From Study of Covid-19 Vaccine in Children 6 to under 12
FTSE Gains, Potential BOE Rate Rise May Not Lift Sterling
U.S. Economic Growth Lost Further Momentum in September -- Chicago Fed
Hertz Orders 100,000 Teslas by End of 2022
Lennox International Sees Positive Forex Impact in Fiscal Year -- Currency Comment
Kimberly-Clark Lowers Full-Year Outlook Amid Higher Input Cost Inflation
Kimberly-Clark 3Q Earnings Squeezed Higher Input Costs
Citigroup Sees Significant Charges from Wind Down of South Korean Consumer Banking Business
Merck's Phase 3 Trials of HIV-1 Treatment Meet Primary Endpoint
Alkermes Gets Fast Track Designation for Ovarian Cancer Treatment
SoftBank Backs TIER at $2 Billion Valuation, Fueling European Scooter Wars
Bausch Health, Clearside Get FDA Approval for Xipere
Merck, Ridgeback: EMA Begins Rolling Review of Covid-19 Pill
FTSE Rises, Sterling Set For Quieter Week After Gains on Rate Rise Bets
EUROPEAN MIDDAY BRIEFING - Stocks Trade Mixed Ahead of US Tech Earnings
North American Morning Briefing: Stock Futures Creep Up Ahead of Tech Earnings
Evaxion Biotech to Study Lead Candidate EVX-01 With Merck's Keytruda
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences